[The correlations and prognostic value of neutrophil to lymphocyte ratio, immunophenotype and cytogenetic abnormalities in patients with newly diagnosed multiple myeloma].
作者信息
Hu J J, Nie S M, Gao Y, Yan X S, Huang J X, Li T L, Liu S S, Mao C X, Zhou J J, Xu Y J, Wang W, Meng F J, Feng X Q
机构信息
Department of Hematology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2019 Dec 14;40(12):1044-1046. doi: 10.3760/cma.j.issn.0253-2727.2019.12.015.
Abstract
摘要
相似文献
1
[The correlations and prognostic value of neutrophil to lymphocyte ratio, immunophenotype and cytogenetic abnormalities in patients with newly diagnosed multiple myeloma].[新诊断多发性骨髓瘤患者中性粒细胞与淋巴细胞比值、免疫表型及细胞遗传学异常的相关性及预后价值]
Zhonghua Xue Ye Xue Za Zhi. 2019 Dec 14;40(12):1044-1046. doi: 10.3760/cma.j.issn.0253-2727.2019.12.015.
2
The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myeloma.克隆大小对多发性骨髓瘤中荧光原位杂交染色体异常预后价值的影响。
Clin Cancer Res. 2015 May 1;21(9):2148-56. doi: 10.1158/1078-0432.CCR-14-2576. Epub 2015 Feb 4.
3
[Cytogenetic Abnormalities and Outcomes of 117 Patients with Multiple Myeloma Detected by FISH].[荧光原位杂交检测117例多发性骨髓瘤患者的细胞遗传学异常及预后]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):127-30. doi: 10.7534/j.issn.1009-2137.2016.01.025.
4
Incidence and Prognostic Significance of High-Risk Cytogenetically Abnormalities in Multiple Myeloma Patients in Colombia.哥伦比亚多发性骨髓瘤患者中高危细胞遗传学异常的发生率和预后意义。
Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):601-607. doi: 10.1016/j.clml.2022.02.006. Epub 2022 Feb 26.
5
The Prognostic Value of the Derived Neutrophil-to-Lymphocyte Ratio in Transplantation-Ineligible Patients with Multiple Myeloma.衍生中性粒细胞与淋巴细胞比值在不符合移植条件的多发性骨髓瘤患者中的预后价值
Acta Haematol. 2018;140(3):157-158. doi: 10.1159/000491988. Epub 2018 Sep 25.
6
[Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].[多发性骨髓瘤患者染色体畸变与预后标志物的相关性——一项单机构研究]
Korean J Lab Med. 2008 Dec;28(6):413-8. doi: 10.3343/kjlm.2008.28.6.413.
7
[Expression of CD56 and CD19 in Patients with Newly Diagnosed Multiple Myeloma and Their Relationship with Karyotypes and Prognosis].[初诊多发性骨髓瘤患者CD56和CD19的表达及其与核型和预后的关系]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Aug;24(4):1071-8. doi: 10.7534/j.issn.1009-2137.2016.04.021.
8
Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients.细胞遗传学异常对多发性骨髓瘤的预后影响：229例患者的回顾性分析
Medicine (Baltimore). 2016 May;95(19):e3521. doi: 10.1097/MD.0000000000003521.
9
[Cytogenetic abnormalities and prognosis of 532 patients with multiple myeloma].532例多发性骨髓瘤患者的细胞遗传学异常与预后
Zhonghua Xue Ye Xue Za Zhi. 2017 Sep 14;38(9):739-743. doi: 10.3760/cma.j.issn.0253-2727.2017.09.002.
10
Pretreatment neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio has a prognostic impact in multiple myeloma.治疗前中性粒细胞/淋巴细胞比值而非血小板/淋巴细胞比值对多发性骨髓瘤具有预后影响。
J Clin Lab Anal. 2017 Sep;31(5). doi: 10.1002/jcla.22107. Epub 2016 Dec 7.
引用本文的文献
1
suPAR: An Inflammatory Mediator for Kidneys.可溶性尿激酶型纤溶酶原激活物受体：肾脏的一种炎症介质。
Kidney Dis (Basel). 2022 Jun 8;8(4):265-274. doi: 10.1159/000524965. eCollection 2022 Jul.
本文引用的文献
1
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.中性粒细胞与淋巴细胞比值（NLR）和血小板与淋巴细胞比值（PLR）作为接受纳武单抗治疗的非小细胞肺癌（NSCLC）患者的预后标志物。
Lung Cancer. 2017 Sep;111:176-181. doi: 10.1016/j.lungcan.2017.07.024. Epub 2017 Jul 24.
2
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.中性粒细胞与淋巴细胞比值及单核细胞与淋巴细胞比值升高，血小板与淋巴细胞比值降低，与多发性骨髓瘤的不良预后相关。
Oncotarget. 2017 Mar 21;8(12):18792-18801. doi: 10.18632/oncotarget.13320.
3
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.突变谱、拷贝数变化与预后：新诊断骨髓瘤患者测序研究结果
J Clin Oncol. 2015 Nov 20;33(33):3911-20. doi: 10.1200/JCO.2014.59.1503. Epub 2015 Aug 17.
4
Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma.多发性骨髓瘤中高危1q21拷贝数畸变的表观遗传起源证据。
Blood. 2015 Jun 11;125(24):3756-9. doi: 10.1182/blood-2015-03-632075. Epub 2015 May 5.
5
Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells.多发性骨髓瘤骨髓间充质基质细胞中的免疫损伤
Cancer Immunol Immunother. 2015 Feb;64(2):213-24. doi: 10.1007/s00262-014-1623-y. Epub 2014 Oct 24.
6
The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age.在60岁以下的经典型霍奇金淋巴瘤患者中，绝对淋巴细胞与单核细胞比值与预后不良相关。
Hematol Oncol. 2015 Sep;33(3):133-40. doi: 10.1002/hon.2155. Epub 2014 Sep 16.
7
Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer.血小板计数与中性粒细胞与淋巴细胞比值的联合是预测行胃癌手术患者术后生存的有用指标。
J Surg Oncol. 2014 Dec;110(8):935-41. doi: 10.1002/jso.23753. Epub 2014 Aug 21.
8
The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer.中性粒细胞与淋巴细胞比值对小细胞肺癌患者的预后影响。
Br J Cancer. 2014 Jul 29;111(3):452-60. doi: 10.1038/bjc.2014.317. Epub 2014 Jun 12.
9
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.术前血小板与淋巴细胞比值升高预示乳腺癌患者预后不良。
Br J Cancer. 2014 May 13;110(10):2524-30. doi: 10.1038/bjc.2014.163. Epub 2014 Mar 27.
10
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.中性粒细胞与淋巴细胞比值可作为弥漫性大 B 细胞淋巴瘤患者独立的预后因素。
Br J Cancer. 2014 Jan 21;110(2):369-74. doi: 10.1038/bjc.2013.763. Epub 2013 Dec 19.
Zotero 插件